Genome Linkage Screen for Prostate Cancer Susceptibility Loci: Results from the Mayo Clinic Familial Prostate Cancer Study

Prostate

Volumn 57, Issue 4, 2003, Pages 335-346

  Cunningham, Julie M ^a   McDonnell, Shannon K ^a   Marks, Angela ^a   Hebbring, Scott ^a   Anderson, Sarah A ^a   Peterson, Brett J ^a   Slager, Susan ^a   French, Amy ^a   Blute, Michael L ^a   Schaid, Daniel J ^a   Thibodeau, Stephen N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chromosome 20; Chromosome X; Linkage analysis; Prostate cancer; Susceptibility locus

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL HETEROGENEITY; CHROMOSOME 20; CHROMOSOME 6; COMPUTER PROGRAM; FAMILIAL CANCER; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MODEL; PEDIGREE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES; X CHROMOSOME;

AGE OF ONSET; AGED; DNA, NEOPLASM; FAMILY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 0344081174     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10308     Document Type: Article

References (55)

1. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. JNCI 1994;86:1600-1608.
2. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17:337-347.
3. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141:732-740.
4. Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL. Cancer in twins: Genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997;89:287-293.
5. Page WF, Braun MM, Partin AW, Caporaso N, Walsh P. Heredity and prostate cancer: A study of World War II veteran twins. Prostate 1997;33:140-145.
6. Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Genetic predisposition, environment, and cancer incidence: A nationwide twin study in Finland, 1976-1995. Int J Cancer 1999;83:743-749.
7. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
8. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992;89:3367-3371.
9. Grönberg H, Damber L, Damber J-E, Iselius L. Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am J Epidemiol 1997;146:552-557.
10. Schaid D, McDonnell S, Blute M, Thibodeau S. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998;62:1425-1438.
11. Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995;1:827-829.
12. Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. Segregation analyses of 1,476 population-based australian families affected by prostate cancer. Am J Hum Genet 2001;68: 1207-1218.
13. Risch N. The genetic epidemiology of cancer: Interpreting familial and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 2001; 10:733-741.
14. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Segregation analysis of prostate cancer in 1,719 white, African-American, and Asian-American families in the United States and Canada. Cancer Causes Control 2002;13:471-482.
15. Smith JR, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujinovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-1374.
16. McIndoe RA, Stanford JL, Gibbs M, Jarvik GP, Brandzel S, Neal CL, Li S, Gammack JT, Gay AA, Goode EL, Hood L, Ostrander EA. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997;61:347-353.
17. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanche H, Bellane-Chantelot C, Demenais F, Teillac P, Le Duc A, de Petriconi R, Hautmann R, Chumakov I, Bachner L, Maitland NJ, Lindereeau R, Vogel W, Fournier G, Mangin P, Cussenot O. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998;62:1416-1424.
18. Eeles RA, Durocher F, Edwards S, Teare D, Badzioch M, Hamoudi R, Gill S, Biggs P, Dearnaley D, Ardern-Jones A, Dowe A, Shearer R, McLennan DL, Norman RL, Ghadirian P, Apridian A, Ford D, Amos C, King TM, Labrie F, Simard J, Narod SA, Easton D, Foulkes WD. Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 1998;62:653-658.
19. Neuhausen SL, Farnham JM, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees. Hum Mol Genet 1999;8:2437-2442.
20. Bergthorsson JT, Johannesdottir G, Arason A, Benediktsdottir KR, Agnarsson BA, Bailey-Wilson JE, Gillanders E, Smith J, Barkardottir RB. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer. Hum Genet 2000;107:372-375.
21. Berry R, Schaid DJ, Smith JR, French AJ, Schroeder JJ, McDonnell SK, Peterson BJ, Wang ZY, Carpten JD, Roberts SG, Tester DJ, Blute ML, Trent JM, Thibodeau SN. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. Am J Hum Genet 2000;66:539-546.
22. Goode EL, Stanford JL, Chakrabarti L, Gibbs M, Kolb S, McIndoe RA, Buckley VA, Schuster EF, Neal CL, Miller EL, Brandzel S, Hood L, Ostrander EA, Jarvik GP. Linkage analysis of 150 high-risk prostate cancer families at 1q24-25. Genet Epidemiol 2000;18:251-275.
23. Hsieh C-L, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh CZ, Halpern J, West DW, Paffenberger RS Jr., Whittemore AS. Re: Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. J Natl Cancer Inst 1997;89:1893-1894.
24. Grönberg H, Smith J, Emanuelsson M, Jonsson B-A, Bergh A, Carpten J, Isaacs W, Xu J, Meyers D, Trent J, Damber J-E. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet 1999;65:134-140.
25. Cooney KA, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, Oesterling JE, Sandler HM, Lange K. Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. J Natl Cancer Inst 1997;89:955-959.
26. Xu J, Genetics ICfPC. Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000;66:945-957.
27. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Buninovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson JE, Walsh P, Isaacs W, Trent J. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-184,
28. Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KAB, Witte JS, Elston RC, Catalona WJ. A genome screen of multiplex prostate cancer sibships. Am J Hum Genet 2000;66:933-944.
29. Gibbs M, Stanford JL, Jarvik GP, Janer M, Badzioch M, Peters MA, Goode EL, Kolb S, Chakrabarti L, Shook M, Basom R, Ostrander EA, Hood L. A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet 2000;67:100-109.
30. Hsieh C-L, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, Kolonel LN, O'Brien LE, Lin IG, Van Den Berg DJ, Teh CZ, West DW, Whittemore AS. A genome screen of families with multiple cases of prostate cancer: Evidence of genetic heterogeneity. Am J Hum Genet 2001;69:148-158.
31. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001; 68:1197-1206.
32. Gibbs M, Stanford JL, Mclndoe RA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, Hood L, Ostrander EA. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999;64:776-787.
33. Gibbs M, Chakrabarti L, Stanford JL, Goode EL, Kolb S, Schuster EF, Buckley VA, Shook M, Hood L, Jarvik GP, Ostrander EA. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am J Hum Genet 1999;64:1087-1095.
34. Whittemore AS, Lin IG, Oakley-Girvan I, Gallagher RP, Halpern J, Kolonel LN, Wu AH, Hsieh C-L. No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. Am J Hum Genet 1999;65:254-256.
35. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujinovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnel S, Schroeder J, Blute M, Thibodeau S, Grönberg H, Emanuelsson M, Damber J-E, Bergh A, Jonsson B-A, Smith J, Bailey-Wilson JE, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van Aucken A, Sood R, Collins F, Brownstein M, Trent J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20:175-179.
36. Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX. Clin Cancer Res 1999;5:4013-4020.
37. Tavtigian S, Simard J, Teng D, Abtin V, Baumgard M, Beck A, Camp N, Carillo A, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland A-M, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA. A strong candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-180.
38. Camp NJ, Tavtigian SV. Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am J Hum Genet 2002;71:1475-1478.
39. Berry R, Schroeder J, French AJ, McDonnell S, Peterson B, Cunningham J, Thibodeau S, Schaid D. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000;67:82-91.
40. Bock CH, Cunningham JM, McDonnell SK, Schaid DJ, Peterson BJ, Pavlic RJ, Schroeder JJ, Klein J, French AJ, Marks A, Thibodeau SN, Lange EM, Cooney KA. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am J Hum Genet 2001;68:795-801.
41. Cancel-Tassin G, Latil A, Valéri A, Guillaume E, Mangin P, Fournier G, Berthou P, Cussenot O. No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer. Int J Cancer 2001;93:455-456.
42. Zheng SL, Xu J, Isaacs SD, Wiley K, Chang B, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families. Hum Genet 2001;108:430-435.
43. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266.
44. Boehnke M, Cox NJ. Accurate inference of relationships in sibpair linkage studies. Am J Hum Genet 1997;61:423-429.
45. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. PNAS 1984;81:3443-3446.
46. Cottingham RW Jr., Idury RM, Schaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet 1993;53:252-263.
47. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996;58:1347-1363.
48. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997;61:1179-1188.
49. Carter B, Bova G, Beaty T, Steinberg G, Childs B, Isaacs W, Walsh P. Hereditary prostate cancer: Epidemiologic and clinical features. J Urol 1993;150:797-802.
50. Ostrander EA, Stanford JL. Genetics of prostate cancer: Too many loci, too few genes. Am J Hum Genet 2000;67:1367-1375.
51. Witte J, Goddard K, Conti D, Elston R, Lin J, Suarez B, Broman K, Burmester J, Weber J, Catalona W. Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000;67: 92-99.
52. Lerner SE, Blute ML, Bergstralh EJ, Bostwick DG, Eickholt JT, Zincke H. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol 1996;156:137-143.
53. Epstein J, Carmichael M, Partin A, Walsh P. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993;149:1478-1781.
54. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS. RNASEL Arg462Gln variant is implicated in up to 13% of prosate cancer cases. Nat Genet 2002;32: 581-583.
55. Slager S, Schaid D, Cunningham J, McDonnell S, Marks A, Peterson B, Hebbring S, Anderson S, French A, Thibodeau S. Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet 2003;72:759-762.